THE EFFECT OF APOLIPOPROTEIN A ON INVITRO APOLIPOPROTEIN C BINDING AND INVIVO REMOVAL OF ARTIFICIAL TRIACYLGLYCEROL-RICH PARTICLES

被引:11
作者
ERKELENS, DW [1 ]
MOCKING, JAJ [1 ]
机构
[1] UNIV HOSP UTRECHT, DEPT INTERNAL MED, CATHARIJNESINGEL 101, 3511 GV UTRECHT, NETHERLANDS
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1985年 / 34卷 / 03期
关键词
D O I
10.1016/0026-0495(85)90004-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the presence of apolipoprotein A on the surface of chylomicrons and its exchange for apolipoprotein C in the mesenteric lymph is known, the functional role of apolipoprotein A in triacylglycerol transport was not elucidated. Mimicking the in vivo situation, artificial triacylglycerol rich particles (TGRP) with which apolipoprotein Al had been associated, were incubated with high-density lipoproteins (HDL). Apo Al-TGRP bound approximately twice as much apolipoproteinC from HDL as nonprotein-containing TGRP, losing 75% of the apolipoprotein Al originally present. To test whether an increased apolipoprotein C binding in vitro implicated an increased removal rate in vivo, boluses of apolipoprotein Al preincubated and control TGRP were given i.v. to 6 hypertriacylglycerolemic patients. The fractional catabolic rate was 35% (range 6-65%) higher for apolipoprotein Al preincubated TGRP than for control TGRP. In accordance with the in vitro incubations, the molar ratio of apolipoprotein C to phospholipid on TGRP reisolated 30 min after injection was 39% (range 12-115%) higher for apo Al triacylglycerol rich particles (TRP) than for control TGRP. The maximal removal capacity of apo Al-TRP, tested in 1 patient by constant infusion, was increased 53% as compared to control TGRP. The function of apolipoprotein Al in triacylglycerol transport may be to enhance apolipoprotein C binding to chylomicrons, which are comparable to TRP and in doing so to enhance their removal from the plasma compartment.
引用
收藏
页码:222 / 226
页数:5
相关论文
共 26 条
[1]   ISOLATION AND CHARACTERIZATION OF HUMAN CHYLE CHYLOMICRONS AND LIPOPROTEINS [J].
ALAUPOVI.P ;
FURMAN, RH ;
FALOR, WH ;
SULLIVAN, ML ;
WALRAVEN, SL ;
OLSON, AC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 149 (A2) :791-+
[2]   STUDIES ON COMPOSITION AND STRUCTURE OF PLASMA LIPOPROTEINS DISTRIBUTION OF LIPOPROTEIN FAMILIES IN MAJOR DENSITY CLASSES OF NORMAL HUMAN PLASMA LIPOPROTEINS [J].
ALAUPOVI.P ;
LEE, DM ;
MCCONATH.WJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (04) :689-&
[3]   QUANTITATION OF APOLIPOPROTEIN A-I OF HUMAN-PLASMA HIGH-DENSITY LIPOPROTEIN [J].
ALBERS, JJ ;
WAHL, PW ;
CABANA, VG ;
HAZZARD, WR ;
HOOVER, JJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (06) :633-644
[4]  
AVOGARO P, 1979, LANCET, V1, P901
[5]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]  
BREWER HB, 1980, ATHEROSCLEROSIS, V5, P680
[8]   AVAILABILITY OF APOLIPOPROTEIN CII IN RELATION TO THE MAXIMAL REMOVAL CAPACITY FOR AN INFUSED TRIGLYCERIDE EMULSION IN MAN [J].
ERKELENS, DW ;
BRUNZELL, JD ;
BIERMAN, EL .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (05) :495-501
[9]   STUDIES OF THE INTERACTION BETWEEN APOLIPOPROTEINS-A AND APOLIPOPROTEINS-C AND TRIACYLGLYCEROL-RICH PARTICLES [J].
ERKELENS, DW ;
CHEN, C ;
MITCHELL, CD ;
GLOMSET, JA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 665 (02) :221-233
[10]   PROTEIN COFACTOR OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE [J].
FIELDING, CJ ;
FIELDING, PE ;
SHORE, VG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1972, 46 (04) :1493-&